These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35435026)

  • 1. Efficacy and Safety of Preoperative Radiotherapy Versus Chemoradiotherapy in Advanced Rectal Cancer: A Meta-analysis of Randomized Controlled Trials.
    Yu M; Wang DC; Li S; Huang LY; Wei J
    Am Surg; 2023 Jun; 89(6):2262-2271. PubMed ID: 35435026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Total Neoadjuvant Treatment Beneficial for Locally Advanced Rectal Cancer? A Meta-Analysis of Randomized Controlled Trials.
    Wu HQ; Li J; Miao JD; Li JW
    Oncology; 2024; 102(5):399-413. PubMed ID: 37926087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 4. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer.
    De Caluwé L; Van Nieuwenhove Y; Ceelen WP
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD006041. PubMed ID: 23450565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and safety of total neoadjuvant therapy versus neoadjuvant chemoradiotherapy in the treatment of locally advanced rectal cancer: a meta-analysis].
    Zhang YQ; Sun KG; Lu JY; Ma J; Yao N; Qin ZH; Yao YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):531-538. PubMed ID: 35754218
    [No Abstract]   [Full Text] [Related]  

  • 6. Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer.
    McCarthy K; Pearson K; Fulton R; Hewitt J
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008368. PubMed ID: 23235660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Locally Advanced Rectal Cancer in the Era of Total Neoadjuvant Therapy: A Systematic Review and Network Meta-Analysis.
    Turri G; Ostuzzi G; Vita G; Barresi V; Scarpa A; Milella M; Mazzarotto R; Ruzzenente A; Barbui C; Pedrazzani C
    JAMA Netw Open; 2024 Jun; 7(6):e2414702. PubMed ID: 38833249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
    Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Analysis of the Efficacy and Safety of Different Neoadjuvant Strategies in the Treatment of Locally Advanced Rectal Cancer.
    Chen W; Wang W; Huang S; Zhou L; Wang G; Chen W
    Cancer Invest; 2024 Jul; ():1-10. PubMed ID: 39037150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
    Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
    Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer.
    Ceelen WP; Van Nieuwenhove Y; Fierens K
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006041. PubMed ID: 19160264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 15. Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR).
    Jin J; Tang Y; Hu C; Jiang LM; Jiang J; Li N; Liu WY; Chen SL; Li S; Lu NN; Cai Y; Li YH; Zhu Y; Cheng GH; Zhang HY; Wang X; Zhu SY; Wang J; Li GF; Yang JL; Zhang K; Chi Y; Yang L; Zhou HT; Zhou AP; Zou SM; Fang H; Wang SL; Zhang HZ; Wang XS; Wei LC; Wang WL; Liu SX; Gao YH; Li YX
    J Clin Oncol; 2022 May; 40(15):1681-1692. PubMed ID: 35263150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis.
    Nakagawa R; Inoue Y; Ohki T; Kaneko Y; Maeda F; Yamamoto M
    World J Surg Oncol; 2017 May; 15(1):112. PubMed ID: 28566093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-field radiotherapy for locally advanced cervical cancer.
    Thamronganantasakul K; Supakalin N; Kietpeerakool C; Pattanittum P; Lumbiganon P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012301. PubMed ID: 30362204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term results of a multicenter phase II study of preoperative chemoradiotherapy with S-1 plus oxaliplatin for locally advanced rectal cancer (JACCRO CC-04: SHOGUN Trial).
    Kondo K; Matsusaka S; Ishihara S; Horie H; Uehara K; Oguchi M; Murafushi K; Ueno M; Mizunuma N; Shimbo T; Kato D; Okuda J; Hashiguchi Y; Nakazawa M; Sunami E; Kawai K; Yamashita H; Okada T; Ishikawa Y; Fujii M; Nakajima T
    Radiother Oncol; 2019 May; 134():199-203. PubMed ID: 31005216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemoradiotherapy for rectal carcinoma: effects on anastomotic leak rate and postoperative bladder dysfunction after non-emergency sphincter-preserving anterior rectal resection. Results of the Quality Assurance in Rectal Cancer Surgery multicenter observational trial.
    Garlipp B; Ptok H; Schmidt U; Meyer F; Gastinger I; Lippert H
    Langenbecks Arch Surg; 2010 Nov; 395(8):1031-8. PubMed ID: 20711786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.